No data available for drug.
DRUG INTERACTION
No drug interaction found for guanethidine and .
rasagiline
may increase the toxic effect of Monoamine Oxidase Inhibitors
bupropion
norepinephrine reuptake inhibitors decrease the effect of guanethidine
maprotiline
norepinephrine reuptake inhibitors decrease the effect of guanethidine
solriamfetol
norepinephrine reuptake inhibitors decrease the effect of guanethidine
viloxazine
norepinephrine reuptake inhibitors decrease the effect of guanethidine
atomoxetine
norepinephrine reuptake inhibitors decrease the effect of guanethidine
noradrenaline
it increases the arrhythmogenic effect of sympathomimetics
oxymetazoline
it increases the arrhythmogenic effect of sympathomimetics
xylometazoline
it increases the arrhythmogenic effect of sympathomimetics
abediterol
may have an increased arrhythmogenic effect when combined with sympathomimetics
atomoxetine
norepinephrine reuptake inhibitors decrease the effect of guanethidine
bupropion
norepinephrine reuptake inhibitors decrease the effect of guanethidine
maprotiline
norepinephrine reuptake inhibitors decrease the effect of guanethidine
solriamfetol
norepinephrine reuptake inhibitors decrease the effect of guanethidine
viloxazine
norepinephrine reuptake inhibitors decrease the effect of guanethidine
lorpiprazole
may decrease the therapeutic effect when combined with guanethidine
lumateperone
may decrease the therapeutic effect when combined with guanethidine
lurasidone
may decrease the therapeutic effect when combined with guanethidine
paliperidone
may decrease the therapeutic effect when combined with guanethidine
perphenazine
may decrease the therapeutic effect when combined with guanethidine
permethrin
it may diminish the excretion rate when combined with permethrin, resulting in an enhanced serum level
tirzepatide
it increases the effect of hypoglycemia on antidiabetic agents
teplizumab
it increases the effect of hypoglycemia on antidiabetic agents
glibenclamide
it increases the effect of hypoglycemia on antidiabetic agents
estropipate
The therapeutic efficacy of guanethidine may be reduced by estrogen derivative
anastrozole
The therapeutic efficacy of guanethidine may be reduced by estrogen derivative
exemestane
The therapeutic efficacy of guanethidine may be reduced by estrogen derivative
formestane
The therapeutic efficacy of guanethidine may be reduced by estrogen derivative
perphenazine
The efficacy of guanethidine could be reduced by the presence of antipsychotic agents
pimavanserin
The efficacy of guanethidine could be reduced by the presence of antipsychotic agents
chlorpromazine
The efficacy of guanethidine could be reduced by the presence of antipsychotic agents
pipotiazine
The efficacy of guanethidine could be reduced by the presence of antipsychotic agents
haloperidol
The efficacy of guanethidine could be reduced by the presence of antipsychotic agents
sitagliptin
it increases the effect of hypoglycemia of antidiabetic agents
linagliptin
it increases the effect of hypoglycemia of antidiabetic agents
maprotiline
norepinephrine reuptake inhibitors decrease the effect of guanethidine
imipramine
norepinephrine reuptake inhibitors decrease the effect of guanethidine
desipramine
norepinephrine reuptake inhibitors decrease the effect of guanethidine
doxepin
norepinephrine reuptake inhibitors decrease the effect of guanethidine
amoxapine
norepinephrine reuptake inhibitors decrease the effect of guanethidine
trimipramine
norepinephrine reuptake inhibitors decrease the effect of guanethidine
naphazoline
may increase the tachycardiac effect of sympathomimetic drugs
orciprenaline
may increase the arrhythmogenic effect of sympathomimetics
salbutamol
may increase the arrhythmogenic effect of sympathomimetics
molindone
may decrease the therapeutic effect of Anticholinergic Agents
No data available for drug.
DRUG INTERACTION
guanethidine
&
No Drug Intearction Found. for guanethidine and .
rasagiline
may increase the toxic effect of Monoamine Oxidase Inhibitors
bupropion
norepinephrine reuptake inhibitors decrease the effect of guanethidine
maprotiline
norepinephrine reuptake inhibitors decrease the effect of guanethidine
solriamfetol
norepinephrine reuptake inhibitors decrease the effect of guanethidine
viloxazine
norepinephrine reuptake inhibitors decrease the effect of guanethidine
atomoxetine
norepinephrine reuptake inhibitors decrease the effect of guanethidine
noradrenaline
it increases the arrhythmogenic effect of sympathomimetics
oxymetazoline
it increases the arrhythmogenic effect of sympathomimetics
xylometazoline
it increases the arrhythmogenic effect of sympathomimetics
abediterol
may have an increased arrhythmogenic effect when combined with sympathomimetics
atomoxetine
norepinephrine reuptake inhibitors decrease the effect of guanethidine
bupropion
norepinephrine reuptake inhibitors decrease the effect of guanethidine
maprotiline
norepinephrine reuptake inhibitors decrease the effect of guanethidine
solriamfetol
norepinephrine reuptake inhibitors decrease the effect of guanethidine
viloxazine
norepinephrine reuptake inhibitors decrease the effect of guanethidine
lorpiprazole
may decrease the therapeutic effect when combined with guanethidine
lumateperone
may decrease the therapeutic effect when combined with guanethidine
lurasidone
may decrease the therapeutic effect when combined with guanethidine
paliperidone
may decrease the therapeutic effect when combined with guanethidine
perphenazine
may decrease the therapeutic effect when combined with guanethidine
permethrin
it may diminish the excretion rate when combined with permethrin, resulting in an enhanced serum level
tirzepatide
it increases the effect of hypoglycemia on antidiabetic agents
teplizumab
it increases the effect of hypoglycemia on antidiabetic agents
glibenclamide
it increases the effect of hypoglycemia on antidiabetic agents
estropipate
The therapeutic efficacy of guanethidine may be reduced by estrogen derivative
anastrozole
The therapeutic efficacy of guanethidine may be reduced by estrogen derivative
exemestane
The therapeutic efficacy of guanethidine may be reduced by estrogen derivative
formestane
The therapeutic efficacy of guanethidine may be reduced by estrogen derivative
perphenazine
The efficacy of guanethidine could be reduced by the presence of antipsychotic agents
pimavanserin
The efficacy of guanethidine could be reduced by the presence of antipsychotic agents
chlorpromazine
The efficacy of guanethidine could be reduced by the presence of antipsychotic agents
pipotiazine
The efficacy of guanethidine could be reduced by the presence of antipsychotic agents
haloperidol
The efficacy of guanethidine could be reduced by the presence of antipsychotic agents
sitagliptin
it increases the effect of hypoglycemia of antidiabetic agents
linagliptin
it increases the effect of hypoglycemia of antidiabetic agents
maprotiline
norepinephrine reuptake inhibitors decrease the effect of guanethidine
imipramine
norepinephrine reuptake inhibitors decrease the effect of guanethidine
desipramine
norepinephrine reuptake inhibitors decrease the effect of guanethidine
doxepin
norepinephrine reuptake inhibitors decrease the effect of guanethidine
amoxapine
norepinephrine reuptake inhibitors decrease the effect of guanethidine
trimipramine
norepinephrine reuptake inhibitors decrease the effect of guanethidine
naphazoline
may increase the tachycardiac effect of sympathomimetic drugs
orciprenaline
may increase the arrhythmogenic effect of sympathomimetics
salbutamol
may increase the arrhythmogenic effect of sympathomimetics
molindone
may decrease the therapeutic effect of Anticholinergic Agents
medtigo
Action and Spectrum
Drug Interaction
Adverse Reaction
Black Box Warning
Contraindication / Caution
Pregnancy / Lactation
Pharmacology
Adminstartion
Patient Information Leaflet